No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion
Reply New Message
Prev Message Back To Forum Threaded View Next Message

& this just back from IR:

"Hello .........Zenith has updated their FAQ section on the website to address the OTC Markets issue to the best they can at this time, with emphasis that this was/is completely out of Zenith’s control (please refer to question #4) https://www.zenithepigenetics.com/about/FAQ

Best regards,

ZEN IR"

so it looks like a person is on their own to get this fixed....

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply